Access Pharmaceuticals Inc. (ACCP.OB) Offers Update on Cobalamin Oral Insulin, Reports 80% Oral Bioavailability
Access Pharmaceuticals Inc. is an emerging biopharmaceutical company that develops and commercializes proprietary products for the treatment and support of cancer patients. Yesterday, the company issued an update on its Cobalamin oral drug delivery product development programs, which is under efficacy and application testing. Cobalamin technology uses vitamin B12 naturally created by the human body to facilitate oral absorption of pharmaceuticals. The company is focused on developing an oral form of insulin and human growth hormone, which currently can only be given through injection. The oral form will offer a more than 80-percent increase in pharmacological response as compared to…